IVBXF(IVBXF)
IVBXF
No analyst ratings available
No analyst price targets available for IVBXF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $19.09B | $22.88B | $27.25B | $33.98B | $38.75B |
| Low | $16.68B | $18.98B | $23.16B | $28.87B | $32.93B |
| High | $31.01B | $26.69B | $37.51B | $46.77B | $53.34B |
| EBITDA Avg | $-3.42B | $-4.10B | $-4.89B | $-6.09B | $-6.95B |
| Low | $-5.56B | $-4.79B | $-6.73B | $-8.39B | $-9.56B |
| High | $-2.99B | $-3.40B | $-4.15B | $-5.18B | $-5.90B |
| EBIT Avg | $-4.40B | $-5.27B | $-6.28B | $-7.83B | $-8.93B |
| Low | $-7.14B | $-6.15B | $-8.64B | $-10.78B | $-12.29B |
| High | $-3.84B | $-4.37B | $-5.33B | $-6.65B | $-7.59B |
| Net Income Avg | $2.49B | $3.97B | $5.43B | $7.78B | $9.70B |
| Low | $2.01B | $3.19B | $4.37B | $6.27B | $7.81B |
| High | $3.71B | $5.91B | $8.10B | $11.60B | $14.45B |
| EPS Avg | $1.43 | $2.28 | $3.12 | $4.47 | $5.57 |
| Low | $1.15 | $1.83 | $2.51 | $3.60 | $4.48 |
| High | $2.13 | $3.39 | $4.65 | $6.66 | $8.30 |
| Analysts (Rev / EPS) | 28 / 1 | 27 / 1 | 18 / 1 | 13 / 1 | 13 / 1 |